InvestSMART

Nanoveu Limited (ASX: NVU) - Announcements

Current share price for NVU : $0.070 0.002 (2.78%)+

ASX company news and announcements for Nanoveu Limited (NVU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Nanoveu Limited (NVU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Nanoveu Limited (NVU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Nanoveu Limited (NVU)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$76 Advancer Global Issues Key Purchase Agreement to Nanoveu 1 Aug 2022 9:54AM $0.011 $0.070 risen by 536.36%
$76 Quarterly Activities/Appendix 4C Cash Flow Report 29 Jul 2022 4:18PM $0.011 $0.070 risen by 536.36%
$76 Application for quotation of securities - NVU 22 Jul 2022 7:11PM $0.014 $0.070 risen by 400%
$76 Notice under Section 708A(5)(e) of the Corporations Act 2001 22 Jul 2022 7:11PM $0.014 $0.070 risen by 400%
$76 Nanoveu Signs MoU to Establish JV in India 30 Jun 2022 9:29AM $0.015 $0.070 risen by 366.67%
$76 Becoming a substantial holder 28 Jun 2022 4:39PM $0.015 $0.070 risen by 366.67%
$76 Results of Meeting 31 May 2022 4:26PM $0.013 $0.070 risen by 438.46%
$76 AGM Presentation 31 May 2022 11:45AM $0.013 $0.070 risen by 438.46%
$76 Notice under Section 708A(5)(e) of the Corporations Act 2001 5 May 2022 4:05PM $0.025 $0.070 risen by 180%
$76 Application for quotation of securities - NVU 5 May 2022 4:04PM $0.025 $0.070 risen by 180%
$76 Notice of Annual General Meeting/Proxy Form 3 May 2022 7:14PM $0.025 $0.070 risen by 180%
$76 Quarterly Activities/Appendix 4C Cash Flow Report 29 Apr 2022 4:15PM $0.025 $0.070 risen by 180%
$76 Nanoshield Antiviral Liquid Spray NEA Listed 6 Apr 2022 4:33PM $0.030 $0.070 risen by 133.33%
$76 Director Nominations 5 Apr 2022 9:44AM $0.034 $0.070 risen by 105.88%
$76 Broker Briefing Investor Webinar Presentation 24 Mar 2022 12:15PM $0.036 $0.070 risen by 94.44%
$76 Broker Briefing Investor Webinar 22 Mar 2022 9:01AM $0.032 $0.070 risen by 118.75%
$76 Nanoveu Launches Disinfection Robot Under a RaaS Model 16 Mar 2022 9:26AM $0.030 $0.070 risen by 133.33%
$76 Trading Halt 15 Mar 2022 10:42AM $0.030 $0.070 risen by 133.33%
$76 Pause in Trading 15 Mar 2022 9:55AM $0.030 $0.070 risen by 133.33%
$76 Nanoshield Accepted as Medical Device in the UK 9 Mar 2022 9:04AM $0.033 $0.070 risen by 112.12%
$76 Nanoshield Files Registration as a Medical Device in the UK 8 Mar 2022 9:47AM $0.032 $0.070 risen by 118.75%
$76 Notification of cessation of securities - NVU 2 Mar 2022 6:32PM $0.026 $0.070 risen by 169.23%
$76 Final Director's Interest Notice 2 Mar 2022 6:31PM $0.026 $0.070 risen by 169.23%
$76 Director Retirement 2 Mar 2022 6:31PM $0.026 $0.070 risen by 169.23%
$76 Appendix 4G and Corporate Governance Statement 1 Mar 2022 8:56AM $0.027 $0.070 risen by 159.26%

401 - 425 of 652 results

Page 17 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.